Annual Total Debt
$2.11 M
-$468.00 K-18.13%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual total debt is $2.11 million, with the most recent change of -$468.00 thousand (-18.13%) on December 31, 2023.
- During the last 3 years, ATNM annual total debt has risen by +$1.38 million (+186.31%).
- ATNM annual total debt is now -18.13% below its all-time high of $2.58 million, reached on December 31, 2022.
Performance
ATNM Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.71 M
-$138.00 K-7.46%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly total debt is $1.71 million, with the most recent change of -$138.00 thousand (-7.46%) on September 30, 2024.
- Over the past year, ATNM quarterly total debt has dropped by -$402.00 thousand (-19.03%).
- ATNM quarterly total debt is now -35.39% below its all-time high of $2.65 million, reached on June 30, 2022.
Performance
ATNM Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ATNM Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.1% | -19.0% |
| 3 y3 years | +186.3% | +306.4% |
| 5 y5 years | +704.6% | +36.7% |
ATNM Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.1% | +581.6% | -35.4% | +768.5% |
| 5 y | 5-year | -18.1% | +581.6% | -35.4% | +768.5% |
| alltime | all time | -18.1% | -100.0% | -35.4% | -100.0% |
Actinium Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.71 M(-7.5%) |
| Jun 2024 | - | $1.85 M(-6.7%) |
| Mar 2024 | - | $1.98 M(-6.2%) |
| Dec 2023 | $2.11 M(-18.1%) | $2.11 M(-4.4%) |
| Sep 2023 | - | $2.21 M(-5.4%) |
| Jun 2023 | - | $2.34 M(-5.0%) |
| Mar 2023 | - | $2.46 M(-4.7%) |
| Dec 2022 | $2.58 M(+732.6%) | $2.58 M(-0.8%) |
| Sep 2022 | - | $2.60 M(-1.8%) |
| Jun 2022 | - | $2.65 M(+1244.2%) |
| Mar 2022 | - | $197.00 K(-36.5%) |
| Dec 2021 | $310.00 K(-58.0%) | $310.00 K(-26.4%) |
| Sep 2021 | - | $421.00 K(-20.4%) |
| Jun 2021 | - | $529.00 K(-16.6%) |
| Mar 2021 | - | $634.00 K(-14.1%) |
| Dec 2020 | $738.00 K(-48.3%) | $738.00 K(-15.8%) |
| Sep 2020 | - | $877.00 K(-19.7%) |
| Jun 2020 | - | $1.09 M(-16.2%) |
| Mar 2020 | - | $1.30 M(-8.8%) |
| Dec 2019 | $1.43 M(+443.8%) | $1.43 M(+14.1%) |
| Sep 2019 | - | $1.25 M(-11.7%) |
| Jun 2019 | - | $1.42 M(-9.9%) |
| Mar 2019 | - | $1.57 M(+499.5%) |
| Dec 2018 | $262.60 K(>+9900.0%) | $262.60 K(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(-100.0%) |
| Jun 2016 | - | $89.60 K(-49.7%) |
| Mar 2016 | - | $178.10 K(-33.0%) |
| Dec 2015 | $265.70 K | $265.70 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $92.30 K(-51.4%) |
| Mar 2015 | - | $189.80 K(-33.1%) |
| Dec 2014 | $283.60 K(+79.7%) | $283.60 K(>+9900.0%) |
| Sep 2014 | - | $0.00(-100.0%) |
| Jun 2014 | - | $55.00 K(-41.8%) |
| Mar 2014 | - | $94.50 K(-40.1%) |
| Dec 2013 | $157.80 K(+12.7%) | $157.80 K(>+9900.0%) |
| Sep 2013 | - | $0.00(-100.0%) |
| Jun 2013 | - | $36.90 K(-50.6%) |
| Mar 2013 | - | $74.70 K(-46.6%) |
| Dec 2012 | $140.00 K(+12.5%) | $140.00 K(+92.0%) |
| Sep 2012 | - | $72.90 K(+2.2%) |
| Jun 2012 | - | $71.30 K(+11.1%) |
| Mar 2012 | - | $64.20 K(-48.4%) |
| Dec 2011 | $124.40 K(>+9900.0%) | $124.40 K(+131.2%) |
| Sep 2011 | - | $53.80 K(0.0%) |
| Jun 2011 | - | $53.80 K(-14.3%) |
| Mar 2011 | - | $62.80 K(>+9900.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2010 | - | $53.60 K(-28.9%) |
| Jun 2010 | - | $75.40 K(+3.3%) |
| Mar 2010 | - | $73.00 K(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2009 | - | $65.40 K(+8.6%) |
| Jun 2009 | - | $60.20 K(+0.2%) |
| Mar 2009 | - | $60.10 K(+20.7%) |
| Dec 2008 | $49.80 K(+38.3%) | $49.80 K(+6.4%) |
| Sep 2008 | - | $46.80 K(+11.4%) |
| Jun 2008 | - | $42.00 K(+7.7%) |
| Mar 2008 | - | $39.00 K(+8.3%) |
| Dec 2007 | $36.00 K(+148.3%) | $36.00 K(+14.3%) |
| Sep 2007 | - | $31.50 K(+51.4%) |
| Jun 2007 | - | $20.80 K(>+9900.0%) |
| Mar 2007 | - | $0.00(-100.0%) |
| Dec 2006 | $14.50 K | $14.50 K(>+9900.0%) |
| Sep 2006 | - | $0.00 |
FAQ
- What is Actinium Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual total debt year-on-year change?
- What is Actinium Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly total debt year-on-year change?
What is Actinium Pharmaceuticals annual total debt?
The current annual total debt of ATNM is $2.11 M
What is the all time high annual total debt for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual total debt is $2.58 M
What is Actinium Pharmaceuticals annual total debt year-on-year change?
Over the past year, ATNM annual total debt has changed by -$468.00 K (-18.13%)
What is Actinium Pharmaceuticals quarterly total debt?
The current quarterly total debt of ATNM is $1.71 M
What is the all time high quarterly total debt for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly total debt is $2.65 M
What is Actinium Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, ATNM quarterly total debt has changed by -$402.00 K (-19.03%)